Item Type | Name |
Concept
|
Central Nervous System Stimulants
|
Concept
|
Autonomic Nervous System
|
Concept
|
Central Nervous System Agents
|
Concept
|
Central Nervous System Depressants
|
Academic Article
|
Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study.
|
Academic Article
|
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
|
Academic Article
|
Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent.
|
Academic Article
|
Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States.
|
Academic Article
|
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.
|
Academic Article
|
In vitro, in vivo and in silico metabolic profiling of a-pyrrolidinopentiothiophenone, a novel thiophene stimulant.
|
Academic Article
|
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020.
|
Academic Article
|
Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age.
|
Academic Article
|
Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances.
|
Academic Article
|
Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
|
Academic Article
|
Novel biomarkers of prenatal methamphetamine exposure in human meconium.
|
Academic Article
|
Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.
|
Academic Article
|
Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.
|
Academic Article
|
Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study.
|
Academic Article
|
Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.
|
Academic Article
|
Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
|
Academic Article
|
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.
|
Academic Article
|
The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.
|
Academic Article
|
Comparative Neuropharmacology and Pharmacokinetics of Methamphetamine and Its Thiophene Analog Methiopropamine in Rodents.
|
Academic Article
|
Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
|
Academic Article
|
Prenatal methamphetamine use and neonatal neurobehavioral outcome.
|
Academic Article
|
Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats.
|
Academic Article
|
Prenatal exposure to tobacco and cannabis: Effects on autonomic and emotion regulation.
|
Academic Article
|
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
|
Academic Article
|
The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age.
|
Academic Article
|
Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.
|
Academic Article
|
Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.
|
Academic Article
|
Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.
|
Academic Article
|
New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.
|
Academic Article
|
School-Aged Outcomes following Prenatal Methamphetamine Exposure: 7.5-Year Follow-Up from the Infant Development, Environment, and Lifestyle Study.
|
Academic Article
|
Prenatal methamphetamine exposure and inhibitory control among young school-age children.
|
Academic Article
|
Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
|
Academic Article
|
Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching.
|
Academic Article
|
Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users.
|
Academic Article
|
Prenatal exposure to tobacco and marijuana and child autonomic regulation and reactivity: An analysis of indirect pathways via maternal psychopathology and parenting.
|
Academic Article
|
Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine.
|
Academic Article
|
The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study.
|
Academic Article
|
Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.
|
Academic Article
|
Methamphetamine disposition in oral fluid, plasma, and urine.
|
Academic Article
|
Behavior Problems During Early Childhood in Children With Prenatal Methamphetamine Exposure.
|